Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

A rare skin reaction from laser hair removal can be prevented with medication.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Chemical fingerprints can distinguish Eclipta prostrata from Wedelia calendulacea to prevent confusion and adulteration.

Extracellular vesicles could revolutionize skincare by improving skin repair and anti-aging, but face regulatory and cost challenges.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

The method effectively showed that the two exemestane preparations are bioequivalent.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Extracellular vesicles can both worsen and potentially treat atopic dermatitis.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Improved CRBN ligands make protein degraders more effective and drug-like.

Estetrol (E4) can help hair grow longer by extending its growth phase.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.